| |
| |
|
Dear readers,
From Geneva’s first-in-Europe partial heart transplant in a child to EPFL’s swallowable bio-printer that “inks” damaged tissue from the inside, this week swings between surgical audacity and miniature robotics. In breast cancer awareness month, a Fribourg-born engineer’s imaging innovation targets the blind spot of dense breasts, while a simple set of “low-tech” aids is quietly improving life for two million Swiss people living with rheumatic disease.
In the lab, Swiss teams go big on data and materials: UZH researchers mine the world’s largest heart-attack datasets to refine treatment timing, and Empa scientists unveil a light-activated, biocompatible coating that zaps pathogens to curb antibiotic resistance.
On the market and policy front, EssilorLuxottica moves to acquire RetinAI, and Swiss Medtech warns of mounting regulatory and tariff pressure, signs of a sector innovating fast under tighter constraints.
Enjoy the read, and see you next Friday.
Your Swiss Digital Health team
|
| |
|
|
| |
| |
|
Click here to filter the news
|
|
|
| |
| |
| |
| |
|
| |
|
Une pilule qui imprime
|
| |
|
Des scientifiques de l’EPFL ont fait la démonstration de la première bio-imprimante de la taille d’une pilule. Celle-ci peut être avalée et guidée dans le tractus gastro-intestinal, où elle dépose directement de la bioencre sur les tissus endommagés afin de faciliter leur réparation.
|
| |
|
From actu.epfl.ch
-
octobre 16, 2025 7:00 AM
|
|
| |
|
|
| |
| |
| |
|
Why deep sighs are actually good for us
|
| |
|
The surface of the lungs is covered with a fluid that increases their deformability. This fluid has the greatest effect when you take deep breaths from time to time, as researchers at ETH Zurich have discovered using sophisticated measurement techniques in the laboratory.
|
| |
|
From ethz.ch
-
octobre 16, 2025 8:00 AM
|
|
| |
|
|
| |
| |
| |
|
EssilorLuxottica acquires RetinAI
|
| |
|
EssilorLuxottica announces the acquisition of Ikerian AG, the Swiss health technology company founded in 2017 and operating under the RetinAI brand, specializing in AI and data management in eyecare. Franco-Italian vision care giant EssilorLuxottica generated consolidated revenue of Euro 26.5 billion in 2024.
|
| |
|
From www.startupticker.ch
-
octobre 16, 2025 2:05 PM
|
|
| |
|
|
| |
| |
| |
| |
|
A weekly dose of digital health insights — curated to save you time.
Created by Swiss Digital Health.
|
| |
|
|
|
|
